<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>14260595530242</udiDi>
    <basicUdiDi>426059553MP24OSD01Z9</basicUdiDi>
    <tradeName>BLUpan® medical OSD</tradeName>
    <deviceName>Sodium Hyaluronate 0.15% - Dexpanthenol Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>42016100</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:52:32.345Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530204</udiDi>
    <basicUdiDi>426059553MP22OSD01YF</basicUdiDi>
    <tradeName>BLUpan® soft OSD</tradeName>
    <deviceName>Sodium Hyaluronate 0.15% Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>42016600</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:52:28.345Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530143</udiDi>
    <basicUdiDi>426059553MP23OSD01YU</basicUdiDi>
    <tradeName>BIOLAN® gel OSD Augentropfen</tradeName>
    <deviceName>Sodium Hyaluronate 0.3% Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>41074200</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:52:27.550Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530105</udiDi>
    <basicUdiDi>426059553MP23UD01K8</basicUdiDi>
    <tradeName>BIOLAN® gel (Muster)</tradeName>
    <deviceName>Sodium Hyaluronate 0.3% Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>41074800</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:52:25.951Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530037</udiDi>
    <basicUdiDi>426059553MP22UD01JV</basicUdiDi>
    <tradeName>BIOLAN® (Muster)</tradeName>
    <deviceName>Sodium Hyaluronate 0.15% Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>41074500</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:52:25.158Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530020</udiDi>
    <basicUdiDi>426059553MP20OSD01XM</basicUdiDi>
    <tradeName>Vizik krople na zmęczone i suche oczy</tradeName>
    <deviceName>Sodium Hyaluronate 0.015% Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41092900</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:52:21.138Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101769</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>YaluVISTA®</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP010010</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:52:17.136Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101752</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP010010</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:52:11.133Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101745</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>YaluVISTA®</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP014010</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:52:09.927Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101738</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP014010</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:52:08.985Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101721</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>YaluVISTA®</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP015010</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:52:07.529Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101714</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP015010</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:52:01.527Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101707</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>YaluVISTA®</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP025010</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:52:00.360Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101691</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP025010</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:59.137Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101684</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>YaluVISTA®</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSV010010</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:57.940Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101677</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSV010010</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:51.926Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101660</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>YaluVISTA®</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSV014010</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:50.992Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101653</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSV014010</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:49.528Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101646</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>YaluVISTA®</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSV015010</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:48.330Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101639</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSV015010</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:42.315Z</lastUpdated>
  </row>
</eudamedExport>